Observational Study on treatment status and adherence in patients with Bipolar disorder Using claims database in Japan.
Not Applicable
- Conditions
- Bipolar disorder
- Registration Number
- JPRN-UMIN000041304
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 13788
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who meet the following 1)Patients who started treatment for Schizophrenia, dementia, autism and ADHD during the enrollment period. 2)Patients who started treatment for bipolar disorder or started treatment with target drug for bipolar disorder for 365 days from the Index date.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method